Endo Health Solutions Inc  

(Public, NASDAQ:ENDP)   Watch this stock  
Find more results for ENDP
34.28
+0.66 (1.96%)
May 23 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 33.39 - 34.36
52 week 25.00 - 38.32
Open 33.73
Vol / Avg. 1.07M/2.69M
Mkt cap 3.85B
P/E     -
Div/yield     -
EPS -5.69
Shares 112.42M
Beta 0.74
Inst. own 105%
Aug 5, 2013
Q2 2013 Endo Health Solutions Inc. Earnings Release Add to calendar
May 22, 2013
Endo Health Solutions Inc. Annual Shareholder Meeting
May 7, 2013
Q1 2013 Endo Health Solutions Inc. Earnings Conference Call - Webcast
Apr 29, 2013
Q1 2013 Endo Health Solutions Inc. Earnings Release
Mar 6, 2013
Endo Health Solutions Inc. at Cowen Health Care Conference - Webcast
Feb 28, 2013
Q4 2012 Endo Health Solutions Inc. Earnings Conference Call - Webcast
Feb 25, 2013
Rajiv De Silva Named President and CEO of Endo Health Solutions - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 3.75% -22.73%
Operating margin 11.56% -18.46%
EBITD margin - 38.14%
Return on average assets 1.65% -9.93%
Return on average equity 5.63% -48.54%
Employees 4,566 -
Carbon Disclosure Rating - -

Address

1400 Atwater Drive
MALVERN, PA 19317
United States - Map
+1-484-2160000 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Endo Health Solutions Inc. is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm , Opana ER, Voltaren Gel, Percocet , Frova , Supprelin LA, Vantas , Valstar and Fortesta Gel. The Company operates in four segments: Endo Pharmaceuticals, Qualitest, AMS, and HealthTronics. Through the Company's HealthTronics segment, the Company provides lithotripsy services, prostate treatment services, anatomical pathology services, medical products manufacturing, sales and maintenance, and information technology solutions. Its products in the Qualitest portfolio includes Endocet, Morphine Sulfate ER, and Hydrocodone. Its AMS products include AMS 700 MS, AMS 800 artificial urinary sphincter, GreenLight XPS laser system, and Monarc subfascial hammock. Its Endo Pharmaceuticals products include Lidoderm, Opana ER, Voltaren Gel, and Percocet.

Officers and directors

Roger H. Kimmel Independent Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
Rajiv De Silva President, Chief Executive Officer, Director
Age: 46
Bio & Compensation  - Reuters
Alan G. Levin Chief Financial Officer, Executive Vice President
Age: 50
Bio & Compensation  - Reuters
Camille Farhat President of American Medical Systems Inc.
Age: 43
Bio & Compensation  - Reuters
Julie H. McHugh Chief Operating Officer
Age: 48
Bio & Compensation  - Reuters
Ivan P. Gergel M.D. Executive Vice President - Research & Development, Chief Scientific Officer
Age: 52
Bio & Compensation  - Reuters
Caroline B. Manogue Executive Vice President, Chief Legal Officer, Secretary
Age: 44
Bio & Compensation  - Reuters
John J. Delucca Independent Director
Age: 68
Bio & Compensation  - Reuters
Nancy J. Hutson Ph.D. Independent Director
Age: 62
Bio & Compensation  - Reuters
Michael Hyatt Independent Director
Age: 67
Bio & Compensation  - Reuters